TELA Bio, Inc.

NasdaqGM:TELA

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🩺 Medical Instruments

Location

United States

Market Cap

USD 68.03 M

Share Price

USD 1.72

Avg Daily Volume

111,911

Change (1 day)

2.99%

Change (1 year)

-57.74%

Change (YTD)

-43.05%

TELA Bio, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD -37.31 M

TELA Bio, Inc. EBITDA is USD -37.31 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 9.23% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

TELA Bio, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -34.16 M, a -14.22% change year over year.
TELA Bio, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -39.83 M, a 25.11% change year over year.
TELA Bio, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -31.83 M, a 24.34% change year over year.
TELA Bio, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -25.60 M, a 31.06% change year over year.